Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

119
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

1

Information Journal Paper

Title

INVESTIGATION OF A PLASMID CONTAINING A NOVEL IMMUNOTOXIN VEGF165-PE38 GENE FOR ANTIANGIOGENIC THERAPY IN A MALIGNANT GLIOMA MODEL

Pages

  2222-2229

Keywords

Not Registered.

Abstract

Cites

References

  • No record.
  • Cite

    APA: Copy

    HU, C.C., & JI, H.M.. (2010). INVESTIGATION OF A PLASMID CONTAINING A NOVEL IMMUNOTOXIN VEGF165-PE38 GENE FOR ANTIANGIOGENIC THERAPY IN A MALIGNANT GLIOMA MODEL. INTERNATIONAL JOURNAL OF CANCER, 127(9), 2222-2229. SID. https://sid.ir/paper/658151/en

    Vancouver: Copy

    HU C.C., JI H.M.. INVESTIGATION OF A PLASMID CONTAINING A NOVEL IMMUNOTOXIN VEGF165-PE38 GENE FOR ANTIANGIOGENIC THERAPY IN A MALIGNANT GLIOMA MODEL. INTERNATIONAL JOURNAL OF CANCER[Internet]. 2010;127(9):2222-2229. Available from: https://sid.ir/paper/658151/en

    IEEE: Copy

    C.C. HU, and H.M. JI, “INVESTIGATION OF A PLASMID CONTAINING A NOVEL IMMUNOTOXIN VEGF165-PE38 GENE FOR ANTIANGIOGENIC THERAPY IN A MALIGNANT GLIOMA MODEL,” INTERNATIONAL JOURNAL OF CANCER, vol. 127, no. 9, pp. 2222–2229, 2010, [Online]. Available: https://sid.ir/paper/658151/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    مرکز اطلاعات علمی SID
    strs
    دانشگاه امام حسین
    بنیاد ملی بازیهای رایانه ای
    کلید پژوه
    ایران سرچ
    ایران سرچ
    File Not Exists.
    Move to top